These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 3055255

  • 1. Suppressive therapy with norfloxacin in patients with recurrent and/or complicated urinary tract infection.
    Falck L, Bucht H, Stegmayr B, Svärd R.
    Scand J Urol Nephrol Suppl; 1988; 110():307-11. PubMed ID: 3055255
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treating acute urinary tract infections. An RCT of 3-day versus 7-day norfloxacin.
    Trienekens TA, London NH, Houben AW, De Jong RA, Stobberingh EE.
    Can Fam Physician; 1993 Mar; 39():514-8. PubMed ID: 8471899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Norfloxacin treatment in complicated urinary tract infection.
    Boerema JB, van Saene HK.
    Scand J Infect Dis Suppl; 1986 Mar; 48():20-6. PubMed ID: 3465030
    [Abstract] [Full Text] [Related]

  • 6. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
    Brumfitt W, Hamilton-Miller JM, Smith GW, al-Wali W.
    Q J Med; 1991 Oct; 81(294):811-20. PubMed ID: 1801054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J, Vila MC, Soriano G, Miñana J, Gana J, Mirelis B, Novella MT, Coll S, Sábat M, Andreu M, Prats G, Solá R, Guarner C.
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.
    Schaeffer AJ, Stuppy BA.
    J Urol; 1999 Jan; 161(1):207-11. PubMed ID: 10037399
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Norfloxacin: a three-day course for the treatment of urinary tract infection.
    Ganguli LA, Keaney MG, Gould LJ.
    Drugs Exp Clin Res; 1985 Jan; 11(3):177-9. PubMed ID: 3836125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O, Boratyńska M, Mróz E, Starek J.
    Pol Tyg Lek; 1985 Jan; 49(6-7):154-7. PubMed ID: 8090671
    [Abstract] [Full Text] [Related]

  • 19. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ.
    Am J Med; 1993 Mar 22; 94(3A):105S-107S. PubMed ID: 8452164
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.